<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0002986" disease_type="Disease or Syndrome" abbrv="">Anderson-Fabry disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e>), an <z:hpo ids='HP_0001417'>X-linked</z:hpo> recessive lysosomal storage disorder caused by a deficiency of α-galactosidase A (α-<z:chebi fb="125" ids="28260">Gal</z:chebi> A) activity, is associated with cardiac manifestations including <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, <z:hpo ids='HP_0001654'>valvular abnormalities</z:hpo>, and <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Early initiation of enzyme replacement therapy (ERT) may have the potential to delay the underlying clinical outcomes in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Clinical electrocardiogram (ECG) and echocardiography were used to characterize the <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e> was performed by measuring the α-<z:chebi fb="125" ids="28260">Gal</z:chebi> A activity in plasma and mutation analysis by direct sequencing using capillary electrophoresis </plain></SENT>
<SENT sid="4" pm="."><plain>We identified four adult hemizygous male patients with <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and other symptoms related to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e>; two of them were monozygotic twins </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> cases, ECG and echocardiography showed severe left ventricular (LV) <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Some years later, <z:hpo ids='HP_0000001'>all</z:hpo> patients showed typical symptoms of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e>, including <z:hpo ids='HP_0001014'>angiokeratomas</z:hpo> and neurological, renal, gastrointestinal, and ocular involvement </plain></SENT>
<SENT sid="7" pm="."><plain>A deficiency of α-<z:chebi fb="125" ids="28260">Gal</z:chebi> A activity and point mutations in exon 5 of the GLA gene were detected in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="8" pm="."><plain>ERT (agalsidase-alfa) was administered every other week as a 0.2 mg/kg intravenous infusion over 40 min </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, these findings highlight the importance of screening middle-aged patients with LV <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> for the early detection of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e>, particularly in direct-line relatives such as twins </plain></SENT>
</text></document>